These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2495677)

  • 1. Effect of L3T4 and Lyt-2 monoclonal antibodies on islet xenograft (rat to mouse) rejection.
    Kawai M; Gotoh M; Monden M; Yamamoto H; Ichikawa T; Valdivia LA; Mori T; Uenaka A; Nakayama E
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2709-10. PubMed ID: 2495677
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful islet allografting requires depletion of both Lyt-2+ and L3T4+ cells.
    Yamamoto H; Monden M; Gotoh M; Ichikawa T; Kubota N; Kawai M; Mori T; Sakurai M; Uenaka A; Nakayama E
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2707-8. PubMed ID: 2495676
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of anti-L3T4 and anti-Lyt 2 monoclonal antibodies on murine cardiac allograft rejection.
    Madsen JC; Wood KJ; Morris PJ
    Transplant Proc; 1987 Oct; 19(5):3991-2. PubMed ID: 3313979
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of the L3T4+ T cell in allograft rejection.
    Hao L; Wang Y; Gill RG; Lafferty KJ
    J Immunol; 1987 Dec; 139(12):4022-6. PubMed ID: 3121726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolongation of islet isograft survival in diabetic NOD mice by anti-L3T4 and anti-LYT2 monoclonal antibodies.
    Matsuo S; Mullen Y; Wicker LS; Peterson LB; Nagata M; Tsunoda T; Clare-Salzler M
    Transplant Proc; 1990 Apr; 22(2):880-1. PubMed ID: 2109427
    [No Abstract]   [Full Text] [Related]  

  • 6. A potential immunosuppressive effect of anti-lymphocyte function-associated antigen-1 monoclonal antibody on islet transplantation.
    Gotoh M; Fukuzaki T; Monden M; Dono K; Kanai T; Yagita H; Okumura K; Mori T
    Transplantation; 1994 Jan; 57(1):123-6. PubMed ID: 7904780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of adhesion molecules in islet allo- and xenograft rejection.
    Gotoh M; Ohzato H; Fukuzaki T; Ohta Y; Nishihara M; Hasuike Y; Umeshita K; Sakon M; Yagita H; Okumura K; Miyasaka M; Monden M
    Transplant Proc; 1996 Apr; 28(2):617. PubMed ID: 8623304
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
    Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
    Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of anti-L3T4 monoclonal antibody treatment on first-set rejection of murine cardiac allografts.
    Madsen JC; Peugh WN; Wood KJ; Morris PJ
    Transplantation; 1987 Dec; 44(6):849-52. PubMed ID: 3321596
    [No Abstract]   [Full Text] [Related]  

  • 10. CD4+ lymphocytes play a dominant role in murine xenograft rejection.
    Pierson RN; Winn HJ; Russell PS; Auchincloss H
    Transplant Proc; 1989 Feb; 21(1 Pt 1):519. PubMed ID: 2565056
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-temperature culture of human islets or in vivo treatment with L3T4 antibody produces a marked prolongation of islet human-to-mouse xenograft survival.
    Ricordi C; Lacy PE; Sterbenz K; Davie JM
    Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8080-4. PubMed ID: 3120184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of rejection of transforming growth factor beta-treated rat-to-mouse islet xenografts by monoclonal antibody to tumor necrosis factor.
    Carel JC; Sheehan KC; Schreiber RD; Lacy PE
    Transplantation; 1993 Feb; 55(2):456-8. PubMed ID: 8434409
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
    Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
    Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in nonobese diabetic mice.
    Miller BJ; Appel MC; O'Neil JJ; Wicker LS
    J Immunol; 1988 Jan; 140(1):52-8. PubMed ID: 3275717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion of graft reactive cells by idarubicin-anti-CD8 (Ly-2.1) immunoconjugate: studies in the mouse heart graft model.
    Mottram PL; Pietersz GA; Purcell LJ; Krauer K; Clunie GJ; McKenzie IF
    Transplant Proc; 1991 Feb; 23(1 Pt 1):499-500. PubMed ID: 1899311
    [No Abstract]   [Full Text] [Related]  

  • 16. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manipulation of pancreatic islet cells in allotransplantation.
    Tze WJ; Tai J
    Transplant Proc; 1982 Dec; 14(4):714-23. PubMed ID: 6820204
    [No Abstract]   [Full Text] [Related]  

  • 18. The synergistic effect of anti-CD4 monoclonal antibodies and cyclosporin A on murine fetal islet allograft survival.
    Burkhardt K; Charlton B; Mandel TE
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2663-4. PubMed ID: 2495663
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolonged survival of fetal pig islet xenografts in mice lacking the capacity for an indirect response.
    Koulmanda M; Laufer TM; Auchincloss H; Smith RN
    Xenotransplantation; 2004 Nov; 11(6):525-30. PubMed ID: 15479462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.
    Barker E; Mokyr MB
    Cancer Res; 1988 Sep; 48(17):4834-42. PubMed ID: 3261626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.